Total Ankle Arthroplasty: Indications, Survivorship, and the Modern Era

Visual Element: An anatomical diagram comparing "Ankle Arthrodesis" (screws crossing the joint) vs "Total Ankle Arthroplasty" (implant in situ), highlighting the preserved subtalar joint motion in the TAR group.

The Renaissance of the Ankle: From the "Forgotten Joint" to the Modern Frontier

For decades, the ankle was widely considered the "forgotten joint" of arthroplasty. While hip and knee replacements evolved into the surgeries of the century, ankle arthritis was largely managed with a single, definitive hammer: Arthrodesis (Fusion).

The rationale was rooted in biomechanics. The ankle joint is unique; it has a remarkably small surface area compared to the knee or hip, yet it routinely absorbs forces equivalent to 5 to 7 times body weight during the push-off phase of normal gait. Furthermore, the ankle is not a simple hinge but a complex, multi-axial joint that functions as a truncated cone. Replicating this kinematic symphony proved incredibly difficult for early engineers and surgeons.

Fusion, therefore, became the reliable operation. It definitively eliminates intra-articular pain by eliminating motion. But the physiological cost of a fused ankle is high. A rigid tibiotalar joint permanently alters gait mechanics, impairs the ability to walk on uneven ground, and places catastrophic, non-physiologic stress on the adjacent joints—primarily the subtalar and talonavicular joints. Radiographic evidence of adjacent segment arthritis approaches nearly 100% within 10 to 20 years post-fusion, often necessitating further complex hindfoot fusions.

Total Ankle Arthroplasty (TAR) promises to solve this adjacent-segment crisis by preserving physiologic motion. But can it consistently deliver? After a rocky, heavily criticized history of early failures, modern TAR has finally entered a golden era, becoming a focal point of modern orthopaedic surgery training and fellowship exam preparation.

A History of Failure (and Redemption)

To truly understand the design principles of modern TAR, one must intimately understand why the earlier iterations failed so spectacularly.

1st Generation (1970s): The Era of Constraint

• Design Philosophy: Highly constrained, rigid, and cemented designs. Conceptually, these were essentially upside-down hip replacements or simple hinges (e.g., the St. Georg or Mayo implants).
• The Failure: Massive osteolysis, rapid component loosening, and catastrophic bone loss. The rigid constraint meant that the immense rotational and shear forces of the gait cycle were transmitted directly to the cement-bone interface. The ankle simply could not handle these constrained forces, resulting in failure rates exceeding 50% within a few years.

2nd Generation (1980s-90s): The Semi-Constrained Compromise

• Design Philosophy: Less constrained, two-component designs (e.g., the original Agility ankle). These often relied on syndesmotic fusion to create a wide, stable base for the tibial component.
• The Failure: While survivorship improved slightly, these implants required massive, unphysiologic bone resection. The reliance on fusing the syndesmosis led to high rates of non-union, subsequent implant subsidence, and instability. When these implants failed, the massive bone voids made salvage arthrodesis exceptionally difficult.

3rd & 4th Generation (The Modern Era): Anatomic and Biologic

• Design Philosophy: Anatomic resurfacing, minimal bone resection, uncemented (biologic fixation), and sophisticated bearing designs. Globally, these are divided into mobile-bearing (widely used in Europe and Australasia, e.g., STAR) and fixed-bearing (heavily favored in the US due to FDA pathways, e.g., Infinity, Vantage).
• The Success: Survivorship now rivals early hip and knee arthroplasty data. By respecting the natural center of rotation and preserving the malleoli, forces are distributed more naturally, dramatically reducing the risk of aseptic loosening.

Modern Implant Design Features

Current market-leading implants (such as the Wright/Stryker Infinity, the Zimmer Biomet Trabecular Metal Ankle, and the Exactech Vantage) share key surgical philosophies that trainees must master:

1. Bone Sparing Resection: Modern cutting jigs allow for minimal resection, preserving the medial and lateral malleoli, as well as the bulk of the talar body. This keeps the door firmly open for a salvage fusion if the implant ultimately fails. In modern surgical education, we teach that "burning bridges" is a thing of the past.
2. Biologic Fixation: Porous titanium matrices, trabecular metal, or hydroxyapatite plasma spray coatings encourage rapid osteointegration. This eliminates the need for bone cement, which historically failed under sheer stress.
3. Advanced Instrumentation and PSI: Patient-specific instrumentation (PSI) utilizing preoperative CT scans and 3D-printed cutting blocks has revolutionized alignment accuracy. This minimizes outliers in coronal and sagittal alignment, which is the number one predictor of implant longevity.
4. The Polyethylene: Highly cross-linked polyethylene (HXLPE) has drastically reduced wear rates and the subsequent risk of macrophage-induced periprosthetic osteolysis, a major culprit of mid-term failures in earlier generations.

Visual Element: A chart showing the "Survival Curve" of modern TARs from the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR), demonstrating ~85-90% survival at the 10-year mark.

Indications: Identifying the "Goldilocks" Patient

Patient selection in TAR is arguably far more critical than in Total Knee Arthroplasty (TKA). The envelope of success is narrower, and straying outside of these boundaries almost guarantees early failure. This is a highly testable area in any FRCS, FRACS, or ABOS examination.

The Ideal Candidate

• Age: Traditionally older (>60 years). However, with improving survivorship data, the indications are slowly creeping down into the 50s for carefully selected patients who understand the potential need for future revision.
• Body Habitus: Normal or slightly elevated BMI. Obesity exerts exponential, destructive force on the remarkably small talar surface area, leading to early subsidence.
• Demand: Low to moderate functional demand. Golf, walking, swimming, and cycling are excellent. Marathon running, heavy manual labor, and high-impact sports are absolute contraindications.
• Alignment: Correctable deformity. A well-aligned hindfoot is mandatory. Coronal plane deformities (varus/valgus) >15° were historically contraindications, but modern adjunctive procedures (deltoid release, lateral ligament reconstruction, calcaneal osteotomies) allow skilled surgeons to push this envelope.
• Pathology: End-stage post-traumatic arthritis (most common), Rheumatoid arthritis (these patients are historically excellent candidates due to their inherently lower physical demand and multi-joint involvement), and primary osteoarthritis.

Absolute Contraindications (Red Flags)

• Active or Latent Infection: Prior deep joint space infection requires exhaustive workup and usually steers the surgeon toward fusion.
• Charcot Neuroarthropathy: The profound loss of protective sensation, coupled with disorganized, hyperemic bone quality, practically guarantees catastrophic implant subsidence and failure.
• Severe Avascular Necrosis (AVN) of the Talus: If >50% of the talar body is necrotic, it will collapse under the metal baseplate. Note: Custom 3D-printed total talar replacements coupled with TAR are an emerging salvage solution, but remain highly specialized.
• Neuromuscular Imbalance: Conditions causing severe spasticity, untreated drop foot, or profound weakness will rock the implant loose due to unphysiologic eccentric loading.
• Poor Soft Tissue Envelope: Previous compromised flaps, severe vascular disease, or dense scarring over the anterior ankle.

Surgical Approaches: Anterior vs. Lateral

Understanding the approach is vital for fellowship exam preparation and clinical practice.

The Anterior Approach: The workhorse approach for the vast majority of TARs (e.g., STAR, Infinity, Vantage). The incision is made directly anteriorly, operating strictly in the internervous/intermuscular plane between the Tibialis Anterior (Deep Peroneal Nerve) and the Extensor Hallucis Longus (Deep Peroneal Nerve).

• Danger: The neurovascular bundle (anterior tibial artery and deep peroneal nerve) lies directly in the field and must be meticulously protected and retracted laterally. The anterior skin is supplied by a delicate watershed angiosome, making it prone to delayed healing if roughly handled.

The Lateral Transfibular Approach: Used primarily by specific implant systems (like the Zimmer Trabecular Metal). It involves a formal fibular osteotomy to access the joint laterally, providing unparalleled visualization of the center of rotation and allowing for a curved talar cut. The fibula is then repaired with a robust plate.

• Danger: Slower overall rehabilitation due to the healing fibular osteotomy, and potential hardware prominence laterally.

Outcomes: The Great Debate - TAR vs. Arthrodesis

The "TAR vs. Fusion" debate is settled not by proving one universally beats the other, but by understanding that they serve entirely different functional goals.

Pain Relief

• Fusion: Remains slightly superior regarding the absolute reliability of complete pain elimination at the tibiotalar joint.
• TAR: Provides excellent, transformative pain relief, but a significant cohort of patients report a persistent "awareness" of the joint or mild aching after heavy use.

Function, Gait, and Proprioception

• TAR: Significantly and measurably superior. Motion analysis studies demonstrate that TAR patients walk faster, exhibit a more symmetrical gait cycle, and navigate stairs and uneven terrain with far greater ease. The preservation of even 25 to 30 degrees of sagittal arc motion dramatically normalizes the kinetic chain.
• Fusion: Patients often walk with a distinct, energy-consuming limp. To clear the foot during the swing phase, they must often externally rotate the limb, putting abnormal stress on the ipsilateral knee.

Survivorship and Longevity

• Fusion: Generally considered a lifetime solution once solid union is achieved. However, the initial non-union rate sits stubbornly at ~5-10%, especially in smokers or diabetics.
• TAR: Current registry data shows 5-year survival >90%, and 10-year survival ~80-85%.
  • Surgical Reality: A "failed" TAR is no longer a disaster. With modular components, isolated polyethylene exchanges are possible. Furthermore, a loose TAR can often be revised to a larger revision TAR stem, or converted to a tibiotalocalcaneal (TTC) fusion using a retrograde intramedullary nail and bulk allograft.

Complications and Management

For orthopaedic surgery trainees, mastering the complications of TAR is just as important as mastering the indications.

1. Wound Healing and Necrosis: The anterior ankle skin relies on tenuous collaterals between the anterior tibial and peroneal arteries. Retractor necrosis or overly aggressive soft tissue stripping leads to delayed wound healing in up to 10-15% of patients. Management requires patience, negative pressure wound therapy, and occasionally plastic surgery intervention.
2. Intra-operative Malleolar Fracture: Occurs in ~5-10% of cases. The medial malleolus is particularly vulnerable when making the sagittal tibial saw cut or during overly aggressive trialing. Management: Must be recognized and internally fixed immediately with screws or a tension band to prevent post-operative instability.
3. Gutter Impingement: Reactive bone overgrowth in the medial or lateral gutters can cause severe, localized pain despite a well-fixed implant. Management: Often successfully treated with arthroscopic debridement.
4. Peri-prosthetic Cysts and Osteolysis: Radiolucent cysts are commonly seen on mid-term follow-up X-rays, particularly around the tibial component. While many are benign and stable, expanding cysts indicate polyethylene wear particle disease. Management: May require prophylactic bone grafting to prevent catastrophic component subsidence.
5. Aseptic Loosening: The ultimate endpoint of a failing implant. Often presents as start-up pain or a change in alignment. Management: Revision arthroplasty or salvage fusion.

Conclusion

Total Ankle Arthroplasty has officially graduated from an "experimental, high-risk" endeavor to an "established, highly successful" cornerstone of modern foot and ankle surgery. The narrative in surgical education is no longer a question of if it works, but precisely who it works for.

For the active, appropriately-aged patient who desperately values motion, wishes to maintain an active lifestyle, and needs to protect their subtalar joint from inevitable degradation, TAR is an undeniably excellent choice. Conversely, for the young manual laborer, the patient with profound neuropathy, or those with severe, uncorrectable multi-planar deformity, ankle arthrodesis remains the undisputed, durable champion.

As surgeons, having both of these powerful tools in our arsenal—and possessing the clinical wisdom to know exactly when to deploy which—is the ultimate key to mastering the complex landscape of ankle arthritis.

References

1. Zaidi R, Cro S, Gurusamy K, et al. "Total ankle replacement versus ankle arthrodesis (TARVA): a randomised controlled trial." Annals of Internal Medicine. 2023.
2. Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR). Annual Report 2024. Foot and Ankle Arthroplasty Data.
3. Clough T, Bodo K, et al. "The evolution of total ankle arthroplasty: from the first generation to the modern era." Bone & Joint Journal. 2020.
4. Glazebrook M, Daniels T, Younger A, et al. "Comparison of health-related quality of life between patients with end-stage ankle and hip arthrosis." Journal of Bone and Joint Surgery (Am). 2008. (A landmark paper highlighting that end-stage ankle arthritis causes disability equivalent to end-stage hip arthritis).
5. Saltzman CL, Mann RA, Ahrens JE, et al. "Prospective controlled trial of STAR total ankle replacement versus ankle fusion: initial results." Foot & Ankle International. 2009.